Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Combination Antibody Therapy for Relapsed Lymphoma and Chronic Lymphocytic Leukemia

This study has been completed.
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) ) Identifier:
First received: August 17, 2001
Last updated: September 24, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2010
  Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)